Medicine Advances (Mar 2024)

Bullous pemphigoid is a rare autoimmune skin disease that affects the scalp: A case report

  • Salkapuram Sunil Kumar,
  • Karthikeyan Elumalai,
  • Navaneetha Krishnan Subramaniyan,
  • Srinivasan Sivannan,
  • Sivaneswari Srinivasan

DOI
https://doi.org/10.1002/med4.47
Journal volume & issue
Vol. 2, no. 1
pp. 95 – 99

Abstract

Read online

Abstract Pemphigoid, a rare autoimmune skin disease affecting the elderly, requires effective pharmacy management. This includes medication therapy, patient education, and counseling. Understanding pharmacokinetics and potential drug interactions are crucial for optimal treatment and minimizing adverse effects. In this case, the patient is a 65‐year‐old male who was diagnosed with pemphigoid 2 months ago. He is currently taking prednisone, an oral corticosteroid, to manage the symptoms. The pharmacist plays a crucial role in medication therapy by monitoring the patient's response to the medication and adjusting the dosage if necessary. Additionally, patient education is vital in ensuring that the patient understands the importance of adherence to the medication regimen and the potential side effects. The pharmacist can also provide counseling on lifestyle modifications and self‐care measures to alleviate symptoms and improve the quality of life. Overall, effective pharmacy management is essential for optimizing treatment outcomes and promoting patient well‐being in pemphigoid cases. The pharmacist's role in pemphigoid cases is crucial for effective medication management and patient education. They monitor the patient's response to treatment, make necessary adjustments, and empower them to take an active role in managing their condition. This approach ultimately improves the overall well‐being of patients with pemphigoid.

Keywords